V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010667 | 310005018 | 1.73 | 63.9 | Curative (C) | 2015-02-23 | 2015-04-05 | EOX | N | N | 310019722 | CISPLATIN + ETOPOSIDE |
| 310010668 | 310005022 | 1.77 | 71 | Palliative (P) | 2017-04-14 | 2017-04-14 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | 02 | N | 310019738 | TRABECTEDIN |
| 310010669 | 310005023 | 1.61 | 66.25 | Curative (C) | 2014-10-20 | 2014-10-23 | Capecitabine + Oxaliplatin 14day | N | null | 310019750 | ICON TRIAL |
| 310010671 | 310005038 | 1.72 | 80.8 | Curative (C) | 2016-05-28 | 2016-11-06 | Cyclophosphamide Fludarabine (Oral) | 02 | N | 310019827 | DABRAFENIB + TRAMETINIB |
| 310010672 | 310010767 | 1.85 | 76.5 | Palliative (P) | 2018-07-13 | 2018-07-14 | Bendamustine + prednisolone | N | N | 310019831 | CEV |
| 310010673 | 310005042 | 1.92 | 37.4 | null | 2014-08-10 | 2014-12-19 | BCG Intravesical | 2 | N | 310019841 | CYTARABINE IT + METHOTREXATE |
| 310010674 | 310011284 | 1.67 | 10.3 | Palliative (P) | 2015-02-08 | 2015-02-09 | ICON8B TRIAL | N | N | 310019847 | OLAPARIB |
| 310010675 | 310005046 | 1.56 | 55 | Curative (C) | 2017-01-10 | 2017-02-02 | ATG | 02 | N | 310019851 | CVD |
| 310010676 | 310005049 | null | 82.7 | Palliative (P) | 2014-02-24 | 2014-05-13 | BEP 5 Day | 2 | N | 310019858 | NIVOLUMAB |
| 310010677 | 310008202 | 1.59 | 60 | Disease modification (D) | 2018-03-21 | 2018-03-31 | Trabectedin | N | N | 310019865 | CISPLATIN + FLUOROURACIL |
| 310010678 | 310008203 | 1.57 | null | Palliative (P) | 2018-04-29 | 2018-07-08 | Paclitaxel albumin (Abraxane) 21day | N | N | 310019870 | OXALIPLATIN + MDG |
| 310010679 | 310005053 | 1.78 | null | Curative (C) | 2016-12-04 | 2016-12-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310019894 | OXALIPLATIN + MDG |
| 310010680 | 310005059 | 1.69 | 62 | Palliative (P) | 2017-02-23 | 2017-08-31 | BEAM + Alemtuzumab Allo SCT | N | N | 310019901 | IPILIMUMAB + NIVOLUMAB |
| 310010682 | 310005064 | 1.73 | 50 | Palliative (P) | 2018-12-12 | 2018-12-13 | GEMCITABINE + CARBO + RITUXIMAB | 2 | N | 310019932 | CYTARABINE IT + METHOTREXATE |
| 310010683 | 310005069 | 1.75 | 99.8 | Palliative (P) | 2016-08-25 | 2016-09-08 | DOXORUBICIN | 02 | null | 310019959 | TRIPLE INTRATHECAL |
| 310010684 | 310008213 | 1.63 | 75 | Disease modification (D) | 2016-11-22 | 2016-12-13 | Vemurafenib | 02 | null | 310019962 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310010685 | 310005076 | 1.57 | 91.4 | Palliative (P) | 2016-11-01 | 2016-11-08 | Cetuximab 14 day | N | N | 310019974 | OXALIPLATIN + MDG |
| 310010686 | 310009875 | null | 46.6 | Curative (C) | 2014-01-09 | 2014-01-09 | Dacarbazine | 02 | N | 310019978 | ABIRATERONE |
| 310010687 | 310005078 | 1.68 | 63 | Disease modification (D) | 2014-04-10 | 2014-09-19 | Capecitabine | Y | N | 310019979 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 310010688 | 310008219 | 0 | 92.1 | Palliative (P) | null | 2019-06-09 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 310019991 | ARSENIC TRIOXIDE + ATRA |
| 310010689 | 310005086 | 1.64 | 47.4 | Palliative (P) | 2018-09-16 | 2018-09-18 | Temozolomide 200mg/m2 | N | N | 310020002 | IMATINIB |
| 310010690 | 310005087 | 1.85 | null | Adjuvant (A) | 2015-09-28 | 2016-01-12 | CYCLO + ETOPOSIDE + NELARABINE | 02 | N | 310020003 | CARBOPLATIN + DOCETAXEL |
| 310010691 | 310005087 | 1.55 | 59.2 | Curative (C) | 2015-07-16 | 2015-07-18 | Palbociclib | 02 | N | 310020003 | CETUXIMAB + IRINOTECAN |
| 310010692 | 310011931 | 1.66 | 69 | Palliative (P) | 2014-02-09 | 2014-03-10 | OXALIPLATIN + MDG + PANITUMUMAB | Y | N | 310020015 | GEMCITABINE + VINORELBINE |
| 310010693 | 310008224 | 1.82 | 63 | Palliative (P) | 2014-09-04 | 2015-11-14 | Doxorubin 50mg/m2 | N | N | 310020025 | PEG INTERFERON |
| 310010694 | 310005093 | 1.4 | 67 | Palliative (P) | 2015-02-26 | 2015-02-27 | TRASTUZUMAB | 2 | N | 310020060 | DOXORUBICIN + OLARATUMAB |
| 310010695 | 310008229 | 1.66 | null | null | 2018-05-12 | 2018-05-13 | LACE | 02 | N | 310020064 | IMATINIB |
| 310010696 | 310009884 | 1.57 | 72 | Curative (C) | 2015-10-30 | 2016-11-11 | MPV (cycle 5-9) - maintenance | N | N | 310020071 | CISPLATIN + PACLITAXEL |
| 310010697 | 310005104 | null | 71.4 | Palliative (P) | 2018-05-16 | 2018-10-03 | Ifosfamide | 2 | N | 310020087 | TRASTUZUMAB |
| 310010698 | 310005105 | 1.78 | 106 | Palliative (P) | null | 2014-07-24 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 310020094 | DABRAFENIB + TRAMETINIB |
| 310010699 | 310005106 | 1.73 | 86.5 | Palliative (P) | 2013-05-10 | 2013-05-24 | CVP R | N | N | 310020108 | MITOMYCIN INTRAVESICULAR |
| 310010700 | 310005108 | 1.69 | 58 | Disease modification (D) | 2015-10-13 | 2015-10-14 | FLUOROURACIL + IRINOTECAN | 02 | N | 310020113 | METHOTREXATE HIGH DOSE |
| 310010701 | 310005109 | 1.8 | 70.2 | Palliative (P) | 2016-09-11 | 2016-09-19 | DHAP | 2 | N | 310020123 | CYTARABINE HD + METHOTREXATE HD |
| 310010702 | 310005111 | 1.79 | 62 | Curative (C) | 2016-12-25 | 2016-12-30 | LANREOTIDE | 02 | N | 310020124 | CHLORAMBUCIL |
| 310010703 | 310009890 | 1.74 | 75.6 | Curative (C) | 2016-07-19 | 2016-07-21 | Erlotinib | 01 | N | 310020155 | CTD |
| 310010704 | 310005118 | 1.9 | 71.6 | Disease modification (D) | 2013-01-12 | 2015-06-16 | Alemtuzumab(INTRAVENOUS) | N | N | 310020163 | CHLORAMBUCIL |
| 310010705 | 310005122 | 1.8 | 58.8 | Palliative (P) | 2015-04-11 | 2015-04-17 | R-GDP | N | N | 310020170 | BEP |
| 310010707 | 310005127 | 1.55 | 86.2 | Palliative (P) | 2014-05-31 | 2014-06-04 | Vinblastine | 2 | N | 310020176 | EOX |
| 310010708 | 310008244 | 1.49 | 59.75 | Palliative (P) | null | 2017-05-28 | BCG Intravesical | N | null | 310020177 | NIVOLUMAB |
| 310010709 | 310005130 | 1.85 | 95.8 | Curative (C) | 2014-04-18 | 2014-04-18 | CETUXIMAB | N | N | 310020179 | TOPOTECAN |
| 310010710 | 310005134 | 0 | 95.6 | null | 2016-09-23 | 2016-11-29 | Methotrexate 10mg/m2 po 7day | 2 | N | 310020192 | CARBO + FLUOROURACIL |
| 310010711 | 310011571 | 1.72 | 98 | Curative (C) | 2017-09-25 | 2017-10-04 | PLUTO TRIAL | 02 | N | 310020193 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 310010712 | 310005136 | null | 69.8 | Palliative (P) | 2018-10-11 | 2018-10-24 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 310020215 | CYTARABINE INTRATHECAL |
| 310010713 | 310005137 | 1.63 | 0 | null | 2015-04-01 | 2015-04-11 | CYTARABINE + ETOPOSIDE + MELPHALAN + THIOTEPA | 2 | N | 310020221 | TEMOZOLOMIDE |
| 310010714 | 310010789 | 1.72 | 70.2 | Palliative (P) | null | 2016-03-09 | Temozolomide 200mg/m2 | N | N | 310020230 | UKALL 2011 |
| 310010715 | 310005142 | 1.73 | 82.4 | Palliative (P) | 2018-05-26 | 2018-10-25 | PEG INTERFERON | N | N | 310020248 | IMATINIB |
| 310010716 | 310005146 | 1.63 | 72.25 | Palliative (P) | 2017-04-29 | 2018-08-21 | IPILIMUMAB + NIVOLUMAB | null | null | 310020268 | CHLORAMBUCIL |
| 310010717 | 310005148 | 1.77 | 78.3 | Curative (C) | 2013-10-04 | 2013-10-05 | Methotrexate High Dose (3g/m2) | N | N | 310020272 | DOXORUBICIN |
| 310010718 | 310005153 | 1.62 | 89.4 | Curative (C) | 2017-01-21 | 2017-01-21 | CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 310021333 | DABRAFENIB + TRAMETINIB |
| 310010719 | 310009904 | 1.77 | 69.6 | Palliative (P) | 2013-11-01 | 2013-12-03 | CAPECITABINE + CARBOPLATIN | N | N | 310023229 | PEG INTERFERON |